Fewer days of opioid use, published in JAMA Network Open.
A peer-reviewed study of people with opioid use disorder, adding WEconnect app-based contingency management to medication for opioid use disorder (MOUD).
In a study published in JAMA Network Open (Marino et al., 2024), people with opioid use disorder who added WEconnect app-based contingency management to their medication for opioid use disorder (MOUD) had about 30 percent fewer days of opioid use than those on MOUD alone.
They also stayed in treatment longer: 61.7 percent were retained, compared with 39.3 percent on MOUD only, and remained in treatment about 54 days longer on average, a 22.9 percent increase in treatment duration.
Contingency management, rewarding verified progress, is the model behind these outcomes, and it scales through the app across a health plan's member population.



